Registered entities
Aprecia Pharmaceuticals Co
Reg. No. 1299458United States
APRECIA PHARMACEUTICALS, LLC
Reg. No. 611852066United States
Aprecia Pharmaceuticals Company
Reg. No. 200457538United States
APRECIA PHARMACEUTICALS, LLC
Reg. No. 32065437991United States
Innovation
18 patent families (12 granted) — focus: Human necessities, Operations & transport; filing pace steady. Cited 4,025 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 10 |
| 2026 | 1 |
Social engagement
Social engagement: 11K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record; lead investors include Deerfield.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Bank & private debt | 2 | 50% |
Recent activity
15 Jun 2026
Event
BIO International 2026
4 Jun 2026
Event
Formulation & Delivery Europe (Discovery & Development by Oxford Global)